Experimental analysis of IC50 values of gemcitabine, BEZ235, GDC-0941, TP-3654, and AUM302 tested in BxPC-3, Capan-2, MIA PaCa-2, PANC-1, and Hs766T pancreatic cancer cell lines.

Comparing the intra-tumoral distribution of Gemcitabine, 5-Fluorouracil, and Capecitabine in a murine model of pancreatic ductal adenocarcinoma.

Louise M Fanchon
James Russell
Nagavarakishore Pillarsetty
Isabella O'Donoghue
Kishore Gangangari
Kenneth H Yu
John L Humm

January 2020

PURPOSE:To develop a technique to compare the intra-tumoral distribution of the drug gemcitabine, it...

Inhibition of cytidine deaminase (CDA) contributes to improved gemcitabine sensitivity.

Naotake Funamizu (182388)
Curtis Ray Lacy (323133)
Kaori Fujita (323134)
Kenei Furukawa (323135)
Takeyuki Misawa (323136)
Katsuhiko Yanaga (323137)
Yoshinobu Manome (323139)

February 2013

A. Levels of CDA mRNA in pancreatic and lung carcinoma cell lines were evaluated by real-t...

DZNep and gemcitabine sensitivity, singly or in combination, and interactions within a panel of pancreatic cell lines.

Sau Wai Hung (102677)
Hardik Mody (442267)
Sean Marrache (442268)
Yangzom D. Bhutia (442269)
Franklin Davis (442270)
Jong Hyun Cho (442271)
Jason Zastre (442272)
Shanta Dhar (442273)
Chung K. Chu (442274)
Rajgopal Govindarajan (102698)

August 2013

A. All cancerous cell lines excluding the normal HPDE are DZNep-responsive and reduced cellular v...

Gemcitabine, BEZ235, GDC-0941, TP-3654, and AUM302 inhibit viability of multiple pancreatic cancer cell lines.

Komala Ingle (17364491)
Joseph F. LaComb (2625181)
Lee M. Graves (425633)
Antonio T. Baines (5200640)
Agnieszka B. Bialkowska (13514014)

November 2023

Pancreatic cancer cell lines BxPC-3 (A), Capan-2 (B), MIA PaCa-2 (C), PANC-1 (D), and Hs766T (E) wer...

Effects of gemcitabine on human pancreatic cancer cells.

Fang Liu (13271)
A. Jesse Gore (506472)
Julie L. Wilson (506473)
Murray Korc (155567)

January 2014

(A) AsPC-1, BxPC-3, and COLO-357 cells were incubated for 48 h in the absence or presence of vary...

Mean IC50 Value of drug (GCB) and dietary molecules (BA and TQ) on three cell lines (MIA PaCa-2; PANC-1; FR2) at 48 hrs.

Archana Pandita (627056)
Bhupender Kumar (430944)
Siddharth Manvati (391250)
Samantha Vaishnavi (627057)
Shashank K. Singh (627058)
Rameshwar N. K. Bamezai (123255)

September 2014

IC50 concentration of the drug (GCB) and Dietary molecules (BA and TQ) in µM co...

Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancers

Rathos Maggie J
Joshi Kavita
Khanwalkar Harshal
Manohar Sonal M
Joshi Kalpana S

August 2012

Abstract Background P276-00 is a novel cyclin-dependent kinase inhibitor currently in Phase II clini...

Cytotoxicity (MTT) (mean±SEM) of KAN0439834, gemcitabine and anti-ROR1 mAb in pancreatic cancer cell lines.

Amir Hossein Daneshmanesh (400461)
Mohammad Hojjat-Farsangi (400459)
Amineh Ghaderi (5328806)
Ali Moshfegh (399257)
Lotta Hansson (825549)
Johan Schultz (2987964)
Jan Vågberg (3041469)
Styrbjörn Byström (2505397)
Elisabeth Olsson (3009450)
Thomas Olin (5328809)
Anders Österborg (246062)
Håkan Mellstedt (3666817)

June 2018

(A) KAN0439834 in PaCa-2 cell line was significantly more effective compared to gemcitabine (p = ...

Gemcitabine sensitivity of PDAC cell lines over-expressing miR-148a.

Yannick Delpu (278672)
Hubert Lulka (261849)
Flavie Sicard (278673)
Nathalie Saint-Laurent (278674)
Frédéric Lopez (278675)
Naïma Hanoun (150348)
Louis Buscail (261874)
Pierre Cordelier (261879)
Jérôme Torrisani (278676)

January 2013

(A) miR-148a endogenous expression level was measured by qRT-PCR in several PDAC cell line...

Half-maximal inhibitory concentration (IC50) of gemcitabine in four biliary tract cancer (BTC) cell lines.

Jaihwan Kim (481708)
Haeryoung Kim (3692143)
Jong-chan Lee (6091127)
Jin Won Kim (224828)
Woo Hyun Paik (481705)
Sang Hyub Lee (5047862)
Jin-Hyeok Hwang (249030)
Ji Kon Ryu (481706)
Yong-Tae Kim (249037)

December 2018

Half-maximal inhibitory concentration (IC50) of gemcitabine in four biliary tract cancer (BTC) cell ...

IC50 of Gemcitabine, Thymoquinone and Betulinic acid at 48 hrs.

Archana Pandita (627056)
Bhupender Kumar (430944)
Siddharth Manvati (391250)
Samantha Vaishnavi (627057)
Shashank K. Singh (627058)
Rameshwar N. K. Bamezai (123255)

September 2014

IC50value was calculated onHuman pancreas adenocarcinomacell l...

Sensitivity of gastric cell lines to gemcitabine in relationship with Bcl-2 expression.

Foong Ying Wong (114500)
Natalia Liem (114504)
Chen Xie (114508)
Fui Leng Yan (114512)
Wing Cheong Wong (114515)
Lingzhi Wang (114519)
Wei-Peng Yong (114522)

December 2012

(A) IC50 of gemcitabine to gastric cancer cell lines. Mean IC50 of ±Standar...

Enhanced drug resistance of SP cells and suppression by cdODN-SOC.

Xiyan Wang (457117)
Quentin Liu (329954)
Benxin Hou (457118)
Wei Zhang (405)
Min Yan (119568)
Huimin Jia (457119)
Haijun Li (290756)
Dong Yan (356556)
Feimeng Zheng (457120)
Wei Ding (690)
Chao Yi (457121)
Hai Wang (310051)

September 2013

(A) Percent cell survival measured by MTT assay in PANC-1 CSCs. All cells were all treated...

IC50 values of compounds MP5-F9, MP5-G9, and CA4 in various cancerous cell lines.

Daniel Tarade (3809002)
Dennis Ma (336906)
Christopher Pignanelli (3809005)
Fadi Mansour (3809011)
Daniel Simard (2445640)
Sean van den Berg (3809008)
James Gauld (2527057)
James McNulty (75590)
Siyaram Pandey (75591)

March 2017

IC50 values of compounds MP5-F9, MP5-G9, and CA4 in various cancerous cell lines.</p

IC50 values (µM) for TP421 and close structural analogs in pancreatic cancer cell lines.

Yumna H. Shabaik (275629)
Melissa Millard (275631)
Nouri Neamati (275633)

January 2013

IC50 values (µM) for TP421 and close structural analogs in pancreatic cancer cell line...

Comparing the intra-tumoral distribution of Gemcitabine, 5-Fluorouracil, and Capecitabine in a murine model of pancreatic ductal adenocarcinoma.

Louise M Fanchon
James Russell
Nagavarakishore Pillarsetty
Isabella O'Donoghue
Kishore Gangangari
Kenneth H Yu
John L Humm

January 2020

PURPOSE:To develop a technique to compare the intra-tumoral distribution of the drug gemcitabine, it...

Inhibition of cytidine deaminase (CDA) contributes to improved gemcitabine sensitivity.

Naotake Funamizu (182388)
Curtis Ray Lacy (323133)
Kaori Fujita (323134)
Kenei Furukawa (323135)
Takeyuki Misawa (323136)
Katsuhiko Yanaga (323137)
Yoshinobu Manome (323139)

February 2013

A. Levels of CDA mRNA in pancreatic and lung carcinoma cell lines were evaluated by real-t...

DZNep and gemcitabine sensitivity, singly or in combination, and interactions within a panel of pancreatic cell lines.

Sau Wai Hung (102677)
Hardik Mody (442267)
Sean Marrache (442268)
Yangzom D. Bhutia (442269)
Franklin Davis (442270)
Jong Hyun Cho (442271)
Jason Zastre (442272)
Shanta Dhar (442273)
Chung K. Chu (442274)
Rajgopal Govindarajan (102698)

August 2013

A. All cancerous cell lines excluding the normal HPDE are DZNep-responsive and reduced cellular v...

Gemcitabine, BEZ235, GDC-0941, TP-3654, and AUM302 inhibit viability of multiple pancreatic cancer cell lines.

Komala Ingle (17364491)
Joseph F. LaComb (2625181)
Lee M. Graves (425633)
Antonio T. Baines (5200640)
Agnieszka B. Bialkowska (13514014)

November 2023

Pancreatic cancer cell lines BxPC-3 (A), Capan-2 (B), MIA PaCa-2 (C), PANC-1 (D), and Hs766T (E) wer...

Effects of gemcitabine on human pancreatic cancer cells.

Fang Liu (13271)
A. Jesse Gore (506472)
Julie L. Wilson (506473)
Murray Korc (155567)

January 2014

(A) AsPC-1, BxPC-3, and COLO-357 cells were incubated for 48 h in the absence or presence of vary...

Mean IC50 Value of drug (GCB) and dietary molecules (BA and TQ) on three cell lines (MIA PaCa-2; PANC-1; FR2) at 48 hrs.

Archana Pandita (627056)
Bhupender Kumar (430944)
Siddharth Manvati (391250)
Samantha Vaishnavi (627057)
Shashank K. Singh (627058)
Rameshwar N. K. Bamezai (123255)

September 2014

IC50 concentration of the drug (GCB) and Dietary molecules (BA and TQ) in µM co...

Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancers

Rathos Maggie J
Joshi Kavita
Khanwalkar Harshal
Manohar Sonal M
Joshi Kalpana S

August 2012

Abstract Background P276-00 is a novel cyclin-dependent kinase inhibitor currently in Phase II clini...

Cytotoxicity (MTT) (mean±SEM) of KAN0439834, gemcitabine and anti-ROR1 mAb in pancreatic cancer cell lines.

Amir Hossein Daneshmanesh (400461)
Mohammad Hojjat-Farsangi (400459)
Amineh Ghaderi (5328806)
Ali Moshfegh (399257)
Lotta Hansson (825549)
Johan Schultz (2987964)
Jan Vågberg (3041469)
Styrbjörn Byström (2505397)
Elisabeth Olsson (3009450)
Thomas Olin (5328809)
Anders Österborg (246062)
Håkan Mellstedt (3666817)

June 2018

(A) KAN0439834 in PaCa-2 cell line was significantly more effective compared to gemcitabine (p = ...

Gemcitabine sensitivity of PDAC cell lines over-expressing miR-148a.

Yannick Delpu (278672)
Hubert Lulka (261849)
Flavie Sicard (278673)
Nathalie Saint-Laurent (278674)
Frédéric Lopez (278675)
Naïma Hanoun (150348)
Louis Buscail (261874)
Pierre Cordelier (261879)
Jérôme Torrisani (278676)

January 2013

(A) miR-148a endogenous expression level was measured by qRT-PCR in several PDAC cell line...

Half-maximal inhibitory concentration (IC50) of gemcitabine in four biliary tract cancer (BTC) cell lines.

Jaihwan Kim (481708)
Haeryoung Kim (3692143)
Jong-chan Lee (6091127)
Jin Won Kim (224828)
Woo Hyun Paik (481705)
Sang Hyub Lee (5047862)
Jin-Hyeok Hwang (249030)
Ji Kon Ryu (481706)
Yong-Tae Kim (249037)

December 2018

Half-maximal inhibitory concentration (IC50) of gemcitabine in four biliary tract cancer (BTC) cell ...

IC50 of Gemcitabine, Thymoquinone and Betulinic acid at 48 hrs.

Archana Pandita (627056)
Bhupender Kumar (430944)
Siddharth Manvati (391250)
Samantha Vaishnavi (627057)
Shashank K. Singh (627058)
Rameshwar N. K. Bamezai (123255)

September 2014

IC50value was calculated onHuman pancreas adenocarcinomacell l...

Sensitivity of gastric cell lines to gemcitabine in relationship with Bcl-2 expression.

Foong Ying Wong (114500)
Natalia Liem (114504)
Chen Xie (114508)
Fui Leng Yan (114512)
Wing Cheong Wong (114515)
Lingzhi Wang (114519)
Wei-Peng Yong (114522)

December 2012

(A) IC50 of gemcitabine to gastric cancer cell lines. Mean IC50 of ±Standar...

Enhanced drug resistance of SP cells and suppression by cdODN-SOC.

Xiyan Wang (457117)
Quentin Liu (329954)
Benxin Hou (457118)
Wei Zhang (405)
Min Yan (119568)
Huimin Jia (457119)
Haijun Li (290756)
Dong Yan (356556)
Feimeng Zheng (457120)
Wei Ding (690)
Chao Yi (457121)
Hai Wang (310051)

September 2013

(A) Percent cell survival measured by MTT assay in PANC-1 CSCs. All cells were all treated...

IC50 values of compounds MP5-F9, MP5-G9, and CA4 in various cancerous cell lines.

Daniel Tarade (3809002)
Dennis Ma (336906)
Christopher Pignanelli (3809005)
Fadi Mansour (3809011)
Daniel Simard (2445640)
Sean van den Berg (3809008)
James Gauld (2527057)
James McNulty (75590)
Siyaram Pandey (75591)

March 2017

IC50 values of compounds MP5-F9, MP5-G9, and CA4 in various cancerous cell lines.</p

IC50 values (µM) for TP421 and close structural analogs in pancreatic cancer cell lines.

Yumna H. Shabaik (275629)
Melissa Millard (275631)
Nouri Neamati (275633)

January 2013

IC50 values (µM) for TP421 and close structural analogs in pancreatic cancer cell line...

Comparing the intra-tumoral distribution of Gemcitabine, 5-Fluorouracil, and Capecitabine in a murine model of pancreatic ductal adenocarcinoma.

Louise M Fanchon
James Russell
Nagavarakishore Pillarsetty
Isabella O'Donoghue
Kishore Gangangari
Kenneth H Yu
John L Humm

January 2020

PURPOSE:To develop a technique to compare the intra-tumoral distribution of the drug gemcitabine, it...

Inhibition of cytidine deaminase (CDA) contributes to improved gemcitabine sensitivity.

Naotake Funamizu (182388)
Curtis Ray Lacy (323133)
Kaori Fujita (323134)
Kenei Furukawa (323135)
Takeyuki Misawa (323136)
Katsuhiko Yanaga (323137)
Yoshinobu Manome (323139)

February 2013

A. Levels of CDA mRNA in pancreatic and lung carcinoma cell lines were evaluated by real-t...

DZNep and gemcitabine sensitivity, singly or in combination, and interactions within a panel of pancreatic cell lines.

Sau Wai Hung (102677)
Hardik Mody (442267)
Sean Marrache (442268)
Yangzom D. Bhutia (442269)
Franklin Davis (442270)
Jong Hyun Cho (442271)
Jason Zastre (442272)
Shanta Dhar (442273)
Chung K. Chu (442274)
Rajgopal Govindarajan (102698)

August 2013

A. All cancerous cell lines excluding the normal HPDE are DZNep-responsive and reduced cellular v...

Experimental analysis of IC<sub>50</sub> values of gemcitabine, BEZ235, GDC-0941, TP-3654, and AUM302 tested in BxPC-3, Capan-2, MIA PaCa-2, PANC-1, and Hs766T pancreatic cancer cell lines.

Abstract

Extracted data

Experimental analysis of IC<sub>50</sub> values of gemcitabine, BEZ235, GDC-0941, TP-3654, and AUM302 tested in BxPC-3, Capan-2, MIA PaCa-2, PANC-1, and Hs766T pancreatic cancer cell lines.

Abstract

Extracted data

Related items

Related items